Back to News
Market Impact: 0.6

Chipotle stock falls despite Stifel reiterating Buy rating amid sales recovery

CMGSFRYKEYTDBMOUBS
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst EstimatesAnalyst InsightsConsumer Demand & RetailArtificial Intelligence
Chipotle stock falls despite Stifel reiterating Buy rating amid sales recovery

Chipotle Mexican Grill (CMG) shares declined 9-10% in after-hours trading following Q2 results, which showed a 4% drop in comparable sales and nearly 5% fewer transactions, despite meeting EPS estimates. This performance, reflecting a challenging consumer environment, led some analysts to lower price targets, while others maintained positive outlooks. However, management noted comparable sales and traffic turned positive in mid-June and July, projecting 2% growth for Q3 and flat for full-year 2025, indicating a potential stabilization and recovery path amidst mixed analyst sentiment.

Analysis

Chipotle Mexican Grill (CMG) experienced a significant 9-10% after-hours share price decline following its second-quarter report, which revealed a 4% drop in comparable sales and a near 5% decrease in transactions. This performance, which missed same-store sales expectations, was attributed to a challenging consumer environment and difficult year-over-year comparisons. Despite the sales slowdown, the company met consensus earnings per share estimates of $0.33 and continues to exhibit strong fundamentals, including a 40.16% gross profit margin and a 43% return on equity. Critically, management indicated a positive inflection point, with comparable sales and traffic returning to growth in mid-June and continuing through July. This recent momentum underpins their guidance for approximately 2% comparable sales growth in Q3, although the full-year 2025 outlook is for roughly flat sales. The situation has created a clear divergence in analyst sentiment, with firms like RBC Capital and KeyBanc lowering price targets to $58 based on the Q2 weakness, while others like Stifel, BMO, and UBS maintained Buy ratings and $65 price targets, focusing on the nascent recovery and strategic initiatives.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo